Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa

Journal of Medical Microbiology
L B GillelandF R Champlin

Abstract

Aminoglycoside-resistant variants of Pseudomonas aeruginosa strain PAO1 were readily selected by culturing the organism in medium containing increasing concentrations of gentamicin, tobramycin or amikacin until the strains were growing in a concentration of drug 128-fold greater than the minimal inhibitory concentration for the sensitive parent strain. These resistant strains exhibited characteristics previously associated with the impermeability type of resistance mechanism, i.e., they grew more slowly than the parent strain, the resistance was unstable in the absence of the antibiotic, and adaptation to one of the antibiotics conferred cross-resistance to other aminoglycosides. The adapted strains grew, with minimal morphological alterations, in concentrations of the various aminoglycosides that normally produced cell envelope damage, misshapen and filamentous cell formation, and cell lysis in the sensitive strain. Neither protein H1 nor phospholipid alterations appear to play a significant role in adaptive resistance to aminoglycoside antibiotics in this model system. The acquisition of adaptive resistance to the aminoglycoside antibiotics did not confer resistance to polymyxin B, another cationic antibiotic which is thought...Continue Reading

Citations

Jul 19, 2013·The Journal of Antimicrobial Chemotherapy·Amanda L RothNancy D Hanson
Jun 1, 1995·British Journal of Clinical Pharmacology·E J BeggS B Duffull
Apr 6, 1999·APMIS. Supplementum·K Fuursted
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·M L BarclayS T Chambers
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Didier HocquetPatrick Plésiat
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Keith Poole
Sep 7, 2000·Microbiology and Molecular Biology Reviews : MMBR·K Lewis
Jun 10, 2014·Canadian Journal of Microbiology·Kanchana PoonsukRungtip Chuanchuen
Apr 19, 2011·International Journal of Antimicrobial Agents·Benjamin M WuHartmut Derendorf
Feb 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lucía FernándezRobert E W Hancock
Feb 26, 2010·Pharmacotherapy·Erin J McDadeDebra L Palazzi
Mar 28, 2013·Journal of Veterinary Pharmacology and Therapeutics·J C NewmanJ L Davis
Jun 1, 2000·Infectious Disease Clinics of North America·D N Fisman, K M Kaye
May 9, 2013·Journal of Proteomics·Idalina MachadoMaria Olívia Pereira
Apr 23, 2016·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Santiago Sandoval-Motta, Maximino Aldana
Oct 23, 2016·Cellular and Molecular Life Sciences : CMLS·T P Tim CushnieAndrew J Lamb
Feb 8, 2000·The Journal of Antimicrobial Chemotherapy·U TattawasartA D Russell
May 29, 2015·Molecular & Cellular Proteomics : MCP·Xia WuJames E Bruce
Apr 18, 2018·Antimicrobial Agents and Chemotherapy·Michael M MaidenChristopher M Waters
Feb 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T Montie, P Patamasucon
Jun 17, 2020·Antimicrobial Agents and Chemotherapy·Devin SindeldeckerPaul Stoodley
Apr 1, 2008·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Sarah K WassilJames W White
Jun 1, 1996·Antimicrobial Agents and Chemotherapy·J A KarlowskyG G Zhanel
Sep 3, 2021·Biofilm·Devin Sindeldecker, Paul Stoodley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S HäusslerI Steinmetz
© 2022 Meta ULC. All rights reserved